University Hospital Muenster
Clinical trials sponsored by University Hospital Muenster, explained in plain language.
-
Targeted radiation blasts brain tumor cells after surgery
Disease control OngoingThis early-phase trial tests a new treatment for glioblastoma, an aggressive brain cancer. After standard therapy (surgery, chemo, radiation), a radioactive drug is injected into the brain cavity to target remaining tumor cells and delay recurrence. The study involves 15 adults a…
Phase: PHASE1 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 16, 2026 23:20 UTC
-
New combo therapy aims to boost survival in kids with aggressive blood cancer
Disease control OngoingThis study tests whether adding the targeted drug rituximab to standard chemotherapy can improve outcomes for children and teens with aggressive B-cell lymphoma or leukemia. About 650 participants from Europe will receive different treatment schedules to find the best balance of …
Phase: PHASE3 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Massive study tests if 3D mammograms find more breast cancers
Diagnosis OngoingThis study compares two types of mammograms for breast cancer screening: a newer 3D method (digital breast tomosynthesis plus a synthesized 2D image) versus the standard 2D digital mammogram. About 100,000 women eligible for Germany's national screening program took part. The goa…
Phase: NA • Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jun 12, 2026 12:03 UTC
-
Can a smartphone app ease end-of-life care? new study explores digital support for patients and families.
Knowledge-focused OngoingThis study looks at whether a web-based platform and app can help patients receiving palliative care at home, along with their families and caregivers, track symptoms and well-being. About 150 adults in North Rhine-Westphalia are using the tool while researchers measure its ease …
Sponsor: University Hospital Muenster • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:19 UTC